INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 45.50
-1.00 (-2.15%)
Oct 10, 2025, 5:07 PM GMT+1
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 46.26 million as of October 10, 2025. Its market cap has decreased by -10.78% in one year.
Market Cap
46.26M
Enterprise Value
82.23M
Revenue
195.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.50
Market Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 46.26M, a decrease of -66.47%. That is a compound annual growth rate of -17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 46.26M | - |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | 334.26M | 142.30% |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.23B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.68B |